|
Reference:
1. Ceftriaxone for injection, USP [package insert]. Silver Spring (MD): U.S. Food and Drug Administration; 2014 [cited 2026 Feb 22]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/065169s022lbl.pdf.
2. GlobalRPH. Ceftriaxone (Rocephin) dilution and stability information [Internet]. GlobalRPH; [cited 2026 Feb 22]. Available from: https://globalrph.com/dilution/ceftriaxone-rocephin/.
3. Micromedex®. IV Compatibility [Internet].2026 [cited 2026 Feb 22]. Available from: https://www.micromedexsolutions.com/.
4. Dybro AM, Damkier P, Rasmussen TB, et al. Statin-associated rhabdomyolysis triggered by drug-drug interaction with itraconazole. BMJ Case Rep. 2016;2016:bcr2016216457.
5. Roques S, Lytrivi M, Rusu D, et al. Rhabdomyolysis-induced acute renal failure due to itraconazole and simvastatin association. Drug Metabol Drug Interact. 2011;26(2):79-80.
6. Kellick KA, Bottorff M, Toth PP, et al. A clinician’s guide to statin drug-drug interactions. J Clin Lipidol. 2014;8(3 Suppl):S30-46.
7. Neuvonen PJ, Kantola T, Kivistö KT. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole. Clin Pharmacol Ther. 1998;63(3):332-341.
8. Uptodate. Drug interactions [Internet]. 2026 [cited 2026 Feb 22]. Available from: https://www.uptodate.com.
Keywords:
ceftriaxone, D5W, itraconazole, simvastatin